年龄相关性黄斑变性的光生物调节

IF 7.8 1区医学 Q1 OPHTHALMOLOGY

JAMA ophthalmology Pub Date : 2025-01-24 DOI:10.1001/jamaophthalmol.2025.0077

Srinivas R. Sadda

引用次数: 0

摘要

本观点考察了光生物调节治疗年龄相关性黄斑变性的LIGHTSIDE试验的结果，并提出了有关试验方案和治疗的有效性和安全性的问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Photobiomodulation for Age-Related Macular Degeneration

This Viewpoint examines results from the LIGHTSIDE trials for photobiomodulation to treat age-related macular degeneration and raises questions regarding the trial protocols and the efficacy and safety of the therapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JAMA ophthalmology OPHTHALMOLOGY-

CiteScore

13.20

自引率

3.70%

发文量

340

期刊介绍： JAMA Ophthalmology, with a rich history of continuous publication since 1869, stands as a distinguished international, peer-reviewed journal dedicated to ophthalmology and visual science. In 2019, the journal proudly commemorated 150 years of uninterrupted service to the field. As a member of the esteemed JAMA Network, a consortium renowned for its peer-reviewed general medical and specialty publications, JAMA Ophthalmology upholds the highest standards of excellence in disseminating cutting-edge research and insights. Join us in celebrating our legacy and advancing the frontiers of ophthalmology and visual science.